Let's talk about deals. Not the kind you make over coffee, but the multi-billion-dollar kind that reshape industries, make headlines, and sometimes end in bankruptcy court. This week had it all: a legendary activist investor eyeing a music giant, a consumer goods behemoth snapping up a vitamin company, and a handful of firms throwing in the towel. Here’s your dispatch from the dealmaking trenches.

New On The Block: Strategic Reviews and Activist Agitation

Sometimes, the biggest news isn't a signed deal, but the signal that one might be coming. That's the vibe in the 'New On The Block' section this week.

First up, mobile gaming company Playtika Holding Corp. (PLTK) is doing what companies do when they want to make shareholders happy: a strategic review. They've brought in Morgan Stanley (MS) to help them "reevaluate strategic alternatives." In plain English, they're looking at all their options—which could mean selling parts of the business, buying something else, or just shaking things up internally. It's the corporate equivalent of checking under the hood.

Then there's a classic activist move. Jorey Chernett, who owns 14.14% of Neuronetics, Inc. (STIM) and is its largest independent shareholder, sent a letter to the board. His message? The company has "chronically underperformed." His proposed fix is pretty direct: start a sale process for Neuronetics' TMS business, and do it immediately. When your biggest outside owner says "sell," the board tends to listen.

On the sadder end of the spectrum, medical device firm MyndTec has run out of road. The company announced it couldn't secure the financing needed to keep going, even after trying a private placement and talking to current and potential investors. The board has now told management to talk to insolvency lawyers. It's a stark reminder that not all strategic alternatives lead to a happy ending.

Updates From The Block: The Big, the Bold, and the Billion-Dollar

This is where the action is. Deals announced, offers made, and industries consolidated.

The blockbuster news comes from Bill Ackman's Pershing Square, which has offered to buy Universal Music Group for approximately $63 billion, according to the Wall Street Journal. The plan? Merge Universal with Pershing Square SPARC Holdings, install Hollywood heavyweight Michael Ovitz as board chairman, and shift the company's stock listing from Amsterdam to the NYSE. It's a massive bet on the music business and a classic Ackman-scale move.

In healthcare, there's serious money moving. Gilead Sciences (GILD) is merging with Tubulis GmbH, a biotech firm focused on antibody-drug conjugates, for $3.15 billion upfront plus up to $1.85 billion in milestone payments. Neurocrine Biosciences (NBIX) is buying Soleno Therapeutics for $2.9 billion. And private equity firm General Atlantic is acquiring home-care company Team Services from Alpine Investors for about $3 billion. Health, it seems, is still wealth.

Consumer goods giant Unilever is making a move into the supplement aisle, agreeing to buy gummy maker Grüns for around $1.2 billion. In wealth management, Miami-based RIA Corient is acquiring Vivaldi Capital, pushing its assets under management to $450 billion. And in real estate, Ares Management (ARES) is buying Whitestone REIT (WSR) for $1.7 billion in cash, taking it private.

The list goes on: Energy Capital Partners is buying nuclear company EnergySolutions from TriArtisan Capital Advisors (price undisclosed). Uplift Investors acquired litigation services firm IMS Legal Strategies. Aeromax Industries, backed by Chimney Rock Equity Partners, bought precision machining firm The Ely Company. And FlexGen Power Systems acquired Clean Energy Services CES to boost its battery storage business. (Financial terms for those last few weren't made public.)

Off The Block: Deals Done and Dusted

Some transactions have already crossed the finish line.

Capital One (COF) has completed its acquisition of Brex Inc. for about $2.56 billion in cash and stock. Sealed Air Corporation is now a private company after completing its acquisition by funds affiliated with CD&R at an enterprise value of $10.3 billion. And HR platform Remote has acquired Paris-based software firm Bravas in a deal valued by VCs at around $3 billion. When the ink is dry, the real work begins.

Bankruptcy Block: When the Music Stops

Not every corporate story has a happy ending. This week's bankruptcy docket is busy.

Spanish Broadcasting System (SBSAA) is moving forward with a prepackaged Chapter 11 filing, backed by key debt holders, to slash its debt and extend maturities. National Road Logistics filed for Chapter 11, listing liabilities up to $50 million. Pacific Rim Winemakers, owned by Banfi Wines, is filing for Chapter 11 to liquidate, blaming a drop in wine consumption, inflation, tariffs, and oversupply.

Then there's Saks Global Enterprises. It's filing a Chapter 11 plan to restructure debt from its $2.7 billion acquisition of Neiman Marcus. The plan is to emerge as "New Saks" with a new board, new vendor deals, and even a cost-cutting move to sell the corporate jet.

Perhaps the most politically charged filing comes from battery recycler Asend Elements. It filed for Chapter 11, citing "insurmountable" financial troubles after the Trump administration canceled a $316 million Department of Energy grant last year. It's a reminder that corporate fortunes can be tied to policy shifts.

So there you have it. A week where some companies are playing offense with huge acquisitions, others are playing defense with strategic reviews, and a few are heading to court for a reset. In the world of deals, it's all just part of the cycle.